| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 9.48e-06 | 138 | 107 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.29e-05 | 127 | 107 | 6 | GO:0016616 | |
| Domain | NHL_repeat_subgr | 1.54e-05 | 9 | 108 | 3 | IPR013017 | |
| Domain | IG_FLMN | 2.19e-05 | 10 | 108 | 3 | SM00557 | |
| Domain | NHL | 2.19e-05 | 10 | 108 | 3 | PF01436 | |
| Domain | NHL_repeat | 2.19e-05 | 10 | 108 | 3 | IPR001258 | |
| Domain | Filamin | 3.00e-05 | 11 | 108 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 3.00e-05 | 11 | 108 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.00e-05 | 11 | 108 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.00e-05 | 11 | 108 | 3 | IPR017868 | |
| Domain | IFI44_fam | 3.31e-05 | 2 | 108 | 2 | IPR024644 | |
| Domain | DUF1088 | 3.31e-05 | 2 | 108 | 2 | IPR010508 | |
| Domain | DUF1088 | 3.31e-05 | 2 | 108 | 2 | PF06469 | |
| Domain | NHL | 5.16e-05 | 13 | 108 | 3 | PS51125 | |
| Domain | FG_GAP | 2.67e-04 | 22 | 108 | 3 | PS51470 | |
| Domain | DUF4704 | 3.28e-04 | 5 | 108 | 2 | IPR031570 | |
| Domain | DUF4704 | 3.28e-04 | 5 | 108 | 2 | PF15787 | |
| Domain | FG-GAP | 3.48e-04 | 24 | 108 | 3 | PF01839 | |
| Domain | FG-GAP | 3.48e-04 | 24 | 108 | 3 | IPR013517 | |
| Domain | PH_BEACH | 4.89e-04 | 6 | 108 | 2 | PF14844 | |
| Domain | SUN | 4.89e-04 | 6 | 108 | 2 | PS51469 | |
| Domain | SUN_dom | 6.83e-04 | 7 | 108 | 2 | IPR012919 | |
| Domain | Sad1_UNC | 6.83e-04 | 7 | 108 | 2 | PF07738 | |
| Domain | PH-BEACH_dom | 9.07e-04 | 8 | 108 | 2 | IPR023362 | |
| Domain | - | 9.07e-04 | 8 | 108 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 9.07e-04 | 8 | 108 | 2 | PS51783 | |
| Domain | Znf-RING_LisH | 9.88e-04 | 34 | 108 | 3 | IPR027370 | |
| Domain | zf-RING_UBOX | 9.88e-04 | 34 | 108 | 3 | PF13445 | |
| Domain | BEACH_dom | 1.16e-03 | 9 | 108 | 2 | IPR000409 | |
| Domain | BEACH | 1.16e-03 | 9 | 108 | 2 | PS50197 | |
| Domain | Beach | 1.16e-03 | 9 | 108 | 2 | PF02138 | |
| Domain | - | 1.16e-03 | 9 | 108 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.16e-03 | 9 | 108 | 2 | SM01026 | |
| Domain | MIP_CS | 1.45e-03 | 10 | 108 | 2 | IPR022357 | |
| Domain | - | 1.48e-03 | 39 | 108 | 3 | 2.120.10.30 | |
| Domain | Integrin_alpha | 1.76e-03 | 11 | 108 | 2 | PF00357 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.38e-03 | 46 | 108 | 3 | IPR011042 | |
| Domain | MIP | 2.88e-03 | 14 | 108 | 2 | PS00221 | |
| Domain | MIP | 2.88e-03 | 14 | 108 | 2 | PF00230 | |
| Domain | - | 3.01e-03 | 169 | 108 | 5 | 3.40.50.720 | |
| Domain | Ig_E-set | 3.12e-03 | 104 | 108 | 4 | IPR014756 | |
| Domain | Bbox_C | 3.31e-03 | 15 | 108 | 2 | IPR003649 | |
| Domain | - | 3.31e-03 | 15 | 108 | 2 | 1.10.150.60 | |
| Domain | MIP | 3.31e-03 | 15 | 108 | 2 | IPR000425 | |
| Domain | BBC | 3.31e-03 | 15 | 108 | 2 | SM00502 | |
| Domain | BRIGHT | 3.31e-03 | 15 | 108 | 2 | SM00501 | |
| Domain | ARID_dom | 3.31e-03 | 15 | 108 | 2 | IPR001606 | |
| Domain | ARID | 3.31e-03 | 15 | 108 | 2 | PS51011 | |
| Domain | - | 3.31e-03 | 15 | 108 | 2 | 1.20.1080.10 | |
| Domain | ARID | 3.31e-03 | 15 | 108 | 2 | PF01388 | |
| Domain | Aquaporin-like | 3.31e-03 | 15 | 108 | 2 | IPR023271 | |
| Domain | NAD(P)-bd_dom | 3.33e-03 | 173 | 108 | 5 | IPR016040 | |
| Domain | Integrin_alpha_C_CS | 3.77e-03 | 16 | 108 | 2 | IPR018184 | |
| Domain | adh_short | 3.97e-03 | 55 | 108 | 3 | PF00106 | |
| Domain | Integrin_alpha-2 | 4.77e-03 | 18 | 108 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 4.77e-03 | 18 | 108 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.77e-03 | 18 | 108 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 4.77e-03 | 18 | 108 | 2 | PS00242 | |
| Domain | ARM-like | 4.84e-03 | 270 | 108 | 6 | IPR011989 | |
| Domain | Int_alpha_beta-p | 5.31e-03 | 19 | 108 | 2 | IPR013519 | |
| Domain | Int_alpha | 5.31e-03 | 19 | 108 | 2 | SM00191 | |
| Pubmed | TRERF1 FLNA DNAJC13 TTC28 GTF3C4 FASN RESF1 ZFHX4 LRBA GCN1 VCPIP1 | 1.07e-07 | 418 | 111 | 11 | 34709266 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 26514622 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNA LDHAL6A ESYT1 OBSCN PSMD9 FLG2 MSR1 ANKAR PALM CC2D2A FH GCN1 | 2.71e-07 | 564 | 111 | 12 | 21565611 |
| Pubmed | FLNA TTC28 PPP1R12A SMCHD1 GTF3C4 FASN ARID2 NFRKB LRBA GCN1 VCPIP1 | 1.57e-06 | 549 | 111 | 11 | 38280479 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DPP7 FLNA PPP1R12A PSMD9 BCAR1 CMYA5 GTF3C4 FASN PTPN12 EIF2S3 PAFAH1B3 NFRKB LRBA FH OGA GCN1 VCPIP1 | 3.70e-06 | 1455 | 111 | 17 | 22863883 |
| Pubmed | 4.23e-06 | 203 | 111 | 7 | 35012549 | ||
| Pubmed | FLNA LDHAL6A MLEC SPTLC2 ESYT1 L2HGDH SRR FASN PAFAH1B3 LRBA FH GCN1 PGM2 | 4.77e-06 | 878 | 111 | 13 | 37223481 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA ESYT1 PPP1R12A SMCHD1 GTF3C4 FASN PTPN12 EIF2S3 ARID2 LRBA OGA GCN1 VCPIP1 | 9.24e-06 | 934 | 111 | 13 | 33916271 |
| Pubmed | FLNA KLF12 AEN FOXK2 PPP1R12A SUN1 OBSCN ZNF600 RESF1 CANT1 AGA NFRKB SUCO RAB11FIP3 | 9.52e-06 | 1084 | 111 | 14 | 11544199 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 32611756 | ||
| Pubmed | β-Actin and fascin-2 cooperate to maintain stereocilia length. | 1.01e-05 | 2 | 111 | 2 | 23658152 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 25229686 | ||
| Pubmed | Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. | 1.01e-05 | 2 | 111 | 2 | 8887669 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 28345280 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21511033 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 9291578 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12714323 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 1.01e-05 | 2 | 111 | 2 | 16325480 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18662770 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA FOXK2 MLEC SPTLC2 ESYT1 SMCHD1 EIF2S3B SBSN FASN PTPN12 TRIM32 GCN1 VCPIP1 | 1.44e-05 | 974 | 111 | 13 | 28675297 |
| Pubmed | 1.88e-05 | 101 | 111 | 5 | 10997877 | ||
| Pubmed | 2.27e-05 | 263 | 111 | 7 | 34702444 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 38989827 | ||
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 3.02e-05 | 3 | 111 | 2 | 30093493 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 28814779 | ||
| Pubmed | Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria. | 3.02e-05 | 3 | 111 | 2 | 31648943 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 38952869 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 25849143 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 27601677 | ||
| Pubmed | Gain-of-Function Mutation in Filamin A Potentiates Platelet Integrin αIIbβ3 Activation. | 3.02e-05 | 3 | 111 | 2 | 28428218 | |
| Pubmed | Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity. | 3.02e-05 | 3 | 111 | 2 | 30602618 | |
| Pubmed | Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. | 3.02e-05 | 3 | 111 | 2 | 9920935 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 9285683 | ||
| Pubmed | MGAT4B OBSCN PSMD9 BCAR1 TUBGCP6 ADAMTS10 PTPN12 ARID2 VPS13A CHCHD2 PALM NDUFAF6 SLC5A12 MSS51 | 3.35e-05 | 1215 | 111 | 14 | 15146197 | |
| Pubmed | 3.47e-05 | 20 | 111 | 3 | 22687584 | ||
| Pubmed | DNAJC13 TTC28 ESYT1 NBEA FLG2 PKHD1L1 ZBED6 EIF2S3 VPS13A LRBA GCN1 | 4.03e-05 | 777 | 111 | 11 | 35844135 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA MGAT4B FOXK2 ESYT1 RDH10 OBSCN ZDHHC8 FASN CANT1 PALM LRBA GCN1 RAB11FIP3 | 5.29e-05 | 1105 | 111 | 13 | 35748872 |
| Pubmed | 5.60e-05 | 534 | 111 | 9 | 35032548 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 5.65e-05 | 807 | 111 | 11 | 30575818 | |
| Pubmed | CD169+ macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling. | 6.03e-05 | 4 | 111 | 2 | 35031565 | |
| Pubmed | Aquaporin 0 Modulates Lens Gap Junctions in the Presence of Lens-Specific Beaded Filament Proteins. | 6.03e-05 | 4 | 111 | 2 | 29196765 | |
| Pubmed | Lens opacity: a new gene for congenital cataract on chromosome 10 of the mouse. | 6.03e-05 | 4 | 111 | 2 | 7333462 | |
| Pubmed | Nephrocystin-1 interacts directly with Ack1 and is expressed in human collecting duct. | 6.03e-05 | 4 | 111 | 2 | 18477472 | |
| Pubmed | Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. | 6.03e-05 | 4 | 111 | 2 | 31836389 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9748319 | ||
| Pubmed | Lens aquaporins function as peroxiporins to facilitate membrane transport of hydrogen peroxide. | 6.03e-05 | 4 | 111 | 2 | 32063362 | |
| Pubmed | FLNA DNAJC13 MLEC ESYT1 PPP1R12A SMCHD1 L2HGDH PSMD9 ERGIC2 FASN PTPN12 TRIM32 EIF2S3 PGM2 | 6.77e-05 | 1297 | 111 | 14 | 33545068 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DNAJC13 FOXK2 MLEC ESYT1 PPP1R12A RDH10 CDH23 PSMD9 GTF3C4 TRIM32 CRNN CHCHD2 BBS12 GCN1 | 8.22e-05 | 1321 | 111 | 14 | 27173435 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 8.61e-05 | 565 | 111 | 9 | 25468996 | |
| Pubmed | 8.75e-05 | 27 | 111 | 3 | 19723784 | ||
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 8.75e-05 | 27 | 111 | 3 | 21143188 | |
| Pubmed | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. | 9.03e-05 | 73 | 111 | 4 | 19027726 | |
| Pubmed | Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. | 9.03e-05 | 73 | 111 | 4 | 25086665 | |
| Pubmed | Functional expression of aquaporins in embryonic, postnatal, and adult mouse lenses. | 1.00e-04 | 5 | 111 | 2 | 17377981 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 12160729 | ||
| Pubmed | Aquaporin expression in developing human teeth and selected orofacial tissues. | 1.00e-04 | 5 | 111 | 2 | 12522663 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 28808245 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 17070019 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNA DNAJC13 MLEC ESYT1 SUN1 ERGIC2 GTF3C4 SBSN ZNF16 FASN PAFAH1B3 ZNF468 HSD17B11 | 1.24e-04 | 1203 | 111 | 13 | 29180619 |
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 1.33e-04 | 31 | 111 | 3 | 2288909 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.39e-04 | 351 | 111 | 7 | 38297188 | |
| Pubmed | 1.46e-04 | 606 | 111 | 9 | 36538041 | ||
| Pubmed | Integrins take partners: cross-talk between integrins and other membrane receptors. | 1.50e-04 | 6 | 111 | 2 | 9789327 | |
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 1.50e-04 | 6 | 111 | 2 | 19482073 | |
| Pubmed | Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation. | 1.50e-04 | 6 | 111 | 2 | 26553386 | |
| Pubmed | Involvement of transmembrane domain interactions in signal transduction by alpha/beta integrins. | 1.50e-04 | 6 | 111 | 2 | 14681217 | |
| Pubmed | 1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell development. | 1.50e-04 | 6 | 111 | 2 | 34762852 | |
| Pubmed | Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses. | 1.50e-04 | 6 | 111 | 2 | 10604475 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 22999953 | ||
| Pubmed | 1.59e-04 | 613 | 111 | 9 | 22268729 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.78e-04 | 256 | 111 | 6 | 33397691 | |
| Pubmed | 1.78e-04 | 87 | 111 | 4 | 12465718 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MLEC SPTLC2 ESYT1 L2HGDH EIF2S3B PSMD9 GTF3C4 FASN TRIM32 EIF2S3 HSD17B11 OGA GCN1 | 1.91e-04 | 1257 | 111 | 13 | 37317656 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 FLNA DNAJC13 GTF3C4 TUBGCP6 PPIG FASN NFRKB OGA VCPIP1 | 1.92e-04 | 774 | 111 | 10 | 15302935 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.01e-04 | 497 | 111 | 8 | 36774506 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 10085298 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 23665963 | ||
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 15669143 | ||
| Pubmed | The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. | 2.10e-04 | 7 | 111 | 2 | 37184585 | |
| Pubmed | 2.41e-04 | 173 | 111 | 5 | 36217029 | ||
| Pubmed | 2.47e-04 | 272 | 111 | 6 | 31010829 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 2.58e-04 | 516 | 111 | 8 | 36610398 | |
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 34131310 | ||
| Pubmed | MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment. | 2.87e-04 | 40 | 111 | 3 | 30759391 | |
| Pubmed | 2.90e-04 | 396 | 111 | 7 | 26687479 | ||
| Pubmed | 2.94e-04 | 397 | 111 | 7 | 21319273 | ||
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 2.99e-04 | 282 | 111 | 6 | 35007762 | |
| Pubmed | 3.09e-04 | 41 | 111 | 3 | 11331580 | ||
| Pubmed | FLNA KLF12 AEN ITFG2 SPTLC2 HSD3B7 FASN ARID2 NFRKB NDUFAF6 OGA GCN1 RAB11FIP3 | 3.21e-04 | 1327 | 111 | 13 | 32694731 | |
| Pubmed | 3.28e-04 | 102 | 111 | 4 | 9734811 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 9736774 | ||
| Pubmed | Wnt pathway anomalies in developing amygdalae of Turner syndrome-like mice. | 3.58e-04 | 9 | 111 | 2 | 17873295 | |
| Pubmed | FLNA DNAJC13 MLEC ESYT1 ERGIC2 ITGA4 TUBGCP6 FASN PAFAH1B3 LRBA OGA GCN1 | 3.61e-04 | 1168 | 111 | 12 | 19946888 | |
| Pubmed | Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. | 4.47e-04 | 10 | 111 | 2 | 10318966 | |
| Pubmed | 4.51e-04 | 707 | 111 | 9 | 19738201 | ||
| Pubmed | 4.56e-04 | 708 | 111 | 9 | 39231216 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 4.63e-04 | 47 | 111 | 3 | 19167335 | |
| Pubmed | 4.88e-04 | 568 | 111 | 8 | 37774976 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.90e-04 | 202 | 111 | 5 | 33005030 | |
| Pubmed | 5.40e-04 | 725 | 111 | 9 | 27025967 | ||
| Interaction | RCOR1 interactions | FLNA KLF12 DNAJC13 FOXK2 TTC28 PPP1R12A PSMD9 FASN RESF1 ZFHX4 LRBA GCN1 VCPIP1 | 3.00e-06 | 494 | 110 | 13 | int:RCOR1 |
| Interaction | GJA1 interactions | FLNA ARHGAP32 ESYT1 SUN1 NBEA ERGIC2 ZDHHC8 HSD3B7 CANT1 VPS13A PALM LRBA HSD17B11 | 1.77e-05 | 583 | 110 | 13 | int:GJA1 |
| Interaction | RAB3GAP1 interactions | 2.01e-05 | 152 | 110 | 7 | int:RAB3GAP1 | |
| Interaction | PIGH interactions | 2.91e-05 | 161 | 110 | 7 | int:PIGH | |
| Cytoband | 19q13.41 | 4.02e-05 | 78 | 111 | 4 | 19q13.41 | |
| Cytoband | 17q25 | 1.18e-04 | 39 | 111 | 3 | 17q25 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 2.80e-04 | 76 | 75 | 4 | 743 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 3.52e-04 | 7 | 75 | 2 | 1350 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.00e-04 | 9 | 75 | 2 | 1230 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.54e-04 | 95 | 75 | 4 | 59 | |
| GeneFamily | Aquaporins | 1.50e-03 | 14 | 75 | 2 | 305 | |
| GeneFamily | AT-rich interaction domain containing | 1.72e-03 | 15 | 75 | 2 | 418 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.49e-03 | 18 | 75 | 2 | 1160 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 3.39e-03 | 21 | 75 | 2 | 980 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.41e-03 | 29 | 75 | 2 | 396 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.66e-08 | 198 | 111 | 8 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.66e-08 | 198 | 111 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-06 | 145 | 111 | 6 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-06 | 156 | 111 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.13e-06 | 175 | 111 | 6 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.84e-06 | 179 | 111 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.27e-06 | 186 | 111 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 7.50e-06 | 187 | 111 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.73e-06 | 188 | 111 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 8.21e-06 | 190 | 111 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.46e-06 | 191 | 111 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.46e-06 | 191 | 111 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.46e-06 | 191 | 111 | 6 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 8.46e-06 | 191 | 111 | 6 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 8.98e-06 | 193 | 111 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 9.25e-06 | 194 | 111 | 6 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 9.25e-06 | 194 | 111 | 6 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 9.80e-06 | 196 | 111 | 6 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | COVID-19_Severe|World / disease group, cell group and cell class | 9.80e-06 | 196 | 111 | 6 | 3bedf60f662b373ad9d0f07d4da9f11864af3a74 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-05 | 197 | 111 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-05 | 199 | 111 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.07e-05 | 199 | 111 | 6 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.07e-05 | 199 | 111 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-05 | 200 | 111 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| ToppCell | Control-PLT_3|Control / Disease Group and Platelet Clusters | 2.67e-05 | 140 | 111 | 5 | 82ea671f61d55f6896d903c5876b042e2f3385d6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.84e-05 | 151 | 111 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 151 | 111 | 5 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 160 | 111 | 5 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 160 | 111 | 5 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 160 | 111 | 5 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 162 | 111 | 5 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.02e-05 | 166 | 111 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 172 | 111 | 5 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 7.12e-05 | 172 | 111 | 5 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 7.12e-05 | 172 | 111 | 5 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-05 | 175 | 111 | 5 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.72e-05 | 175 | 111 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.72e-05 | 175 | 111 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-05 | 176 | 111 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 8.15e-05 | 177 | 111 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 8.82e-05 | 180 | 111 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.82e-05 | 180 | 111 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.05e-05 | 181 | 111 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 9.29e-05 | 182 | 111 | 5 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.29e-05 | 182 | 111 | 5 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 185 | 111 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 185 | 111 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.00e-04 | 185 | 111 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.03e-04 | 186 | 111 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-04 | 189 | 111 | 5 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.11e-04 | 189 | 111 | 5 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 190 | 111 | 5 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 190 | 111 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-04 | 190 | 111 | 5 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 1.14e-04 | 190 | 111 | 5 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.14e-04 | 190 | 111 | 5 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 190 | 111 | 5 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 190 | 111 | 5 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 190 | 111 | 5 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 190 | 111 | 5 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 190 | 111 | 5 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.16e-04 | 191 | 111 | 5 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.16e-04 | 191 | 111 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 191 | 111 | 5 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 191 | 111 | 5 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 191 | 111 | 5 | b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.19e-04 | 192 | 111 | 5 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.19e-04 | 192 | 111 | 5 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.19e-04 | 192 | 111 | 5 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 1.19e-04 | 192 | 111 | 5 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.19e-04 | 192 | 111 | 5 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.19e-04 | 192 | 111 | 5 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 193 | 111 | 5 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 1.22e-04 | 193 | 111 | 5 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 193 | 111 | 5 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-04 | 193 | 111 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 193 | 111 | 5 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.22e-04 | 193 | 111 | 5 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 193 | 111 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.22e-04 | 193 | 111 | 5 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.22e-04 | 193 | 111 | 5 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 193 | 111 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-04 | 193 | 111 | 5 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 193 | 111 | 5 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 193 | 111 | 5 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-04 | 194 | 111 | 5 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.25e-04 | 194 | 111 | 5 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.25e-04 | 194 | 111 | 5 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 1.25e-04 | 194 | 111 | 5 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 195 | 111 | 5 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 195 | 111 | 5 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 195 | 111 | 5 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 195 | 111 | 5 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.28e-04 | 195 | 111 | 5 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.28e-04 | 195 | 111 | 5 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-04 | 195 | 111 | 5 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.28e-04 | 195 | 111 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 5.18e-08 | 3 | 111 | 3 | DOID:0110282 (implicated_via_orthology) | |
| Disease | galectin-3-binding protein measurement | 1.03e-06 | 6 | 111 | 3 | EFO_0010241 | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 1.40e-05 | 2 | 111 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:0060214 (implicated_via_orthology) | |
| Disease | Parkinson's disease 22 (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:0080504 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy, Jokela type (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:0081356 (implicated_via_orthology) | |
| Disease | hypopituitarism (implicated_via_orthology) | 2.08e-04 | 6 | 111 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | psoriasis (implicated_via_orthology) | 2.91e-04 | 7 | 111 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | leukodystrophy (implicated_via_orthology) | 4.96e-04 | 9 | 111 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:2 measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0010429 | |
| Disease | Ciliopathies | 8.06e-04 | 110 | 111 | 4 | C4277690 | |
| Disease | granulins measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0008141 | |
| Disease | Influenza | 1.00e-03 | 52 | 111 | 3 | C0021400 | |
| Disease | Polydactyly | 1.01e-03 | 117 | 111 | 4 | C0152427 | |
| Disease | lymphocyte measurement | 1.01e-03 | 117 | 111 | 4 | EFO_0803546 | |
| Disease | Pneumoconiosis | 1.24e-03 | 14 | 111 | 2 | C0032273 | |
| Disease | Bagassosis | 1.24e-03 | 14 | 111 | 2 | C0004681 | |
| Disease | Disorder of eye | 1.26e-03 | 212 | 111 | 5 | C0015397 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.84e-03 | 17 | 111 | 2 | C2936862 | |
| Disease | Schizophrenia | KLF12 ARHGAP32 SRR CMYA5 ZDHHC8 JARID2 PTPRZ1 AGA SLC17A7 MSS51 | 1.86e-03 | 883 | 111 | 10 | C0036341 |
| Disease | Bardet-Biedl syndrome | 2.06e-03 | 18 | 111 | 2 | cv:C0752166 | |
| Disease | aspartate aminotransferase measurement | 2.20e-03 | 904 | 111 | 10 | EFO_0004736 | |
| Disease | platelet-to-lymphocyte ratio | 2.55e-03 | 363 | 111 | 6 | EFO_0008446 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.81e-03 | 21 | 111 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.97e-03 | 157 | 111 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | progranulin measurement | 3.08e-03 | 22 | 111 | 2 | EFO_0004625 | |
| Disease | lymphocyte percentage of leukocytes | 3.69e-03 | 665 | 111 | 8 | EFO_0007993 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIDGVHLGQAVHVSG | 356 | Q0P6H9 | |
| IQVGQHGHSSVEDAT | 246 | Q8WTP8 | |
| GILVSQHSGVEAHSH | 911 | Q9BSJ8 | |
| KVAQHLTGASHGDNV | 1106 | Q9HCE0 | |
| VHQTLVAHGQALDAG | 551 | P56945 | |
| AVAGAHVVIHTAGLV | 76 | Q9H2F3 | |
| ERIINHAAGSHGVSG | 276 | Q96RQ1 | |
| SSSNGQAHIHVVGVK | 586 | Q68CP9 | |
| ATLAQSVGHISGAHL | 61 | P29972 | |
| ALLENGAHVNGVTVH | 116 | Q8WXH4 | |
| KNNHGHIVTVASAAG | 161 | Q8NBQ5 | |
| TDSEIITGHGHTQIN | 686 | Q6ZW61 | |
| GIHVVHGSTGTLLAT | 3281 | Q9H251 | |
| VAVGSAVGHTLGHAI | 66 | Q9Y6H1 | |
| GHLQGQASTSHVAIS | 126 | Q9H324 | |
| VQSVGHISGAHVNPA | 56 | P30301 | |
| KVVHAVDGTAENGIH | 211 | O75781 | |
| HGQSVITVIGGEEHF | 376 | O75154 | |
| NHVKVTSEALGHAGR | 311 | A4D126 | |
| VGTNNHGHTAEQVTG | 101 | Q15102 | |
| HGHTAEQVTGGIKAI | 106 | Q15102 | |
| THKSAVHALVEAGGI | 771 | Q7Z5J8 | |
| AHQGIAVLGSDTVHQ | 1636 | Q8N7Z5 | |
| HGQAGSQHGESESIV | 1826 | Q5D862 | |
| AGQTITVATHAKQGA | 1101 | Q6P4R8 | |
| FQHVGTHSSLAGKIQ | 366 | Q9UQ53 | |
| AVHQTGHNSGVIHSG | 86 | Q9H9P8 | |
| GGSTVHVVGASHVET | 261 | Q4VC12 | |
| TQNGTHVASVPTAVH | 576 | Q01167 | |
| IHTNQAESHTAVGRG | 291 | Q13201 | |
| AVNAGGEAHVDVHGI | 51 | Q14165 | |
| SVKSIFHGHVTGQAV | 216 | Q53G44 | |
| FHGHVTGQAVVGSDI | 221 | Q53G44 | |
| AVSHVGAVVPTHGFS | 331 | Q8WVQ1 | |
| DHAASHIGKAQGIVT | 201 | Q330K2 | |
| THTGQVLGSLVHVKG | 36 | O00748 | |
| VHTSVHGVGHSFVQS | 251 | Q96G03 | |
| HSIQSAMHSIGGVQV | 461 | P50851 | |
| IHGHVSNASIRVGEN | 1106 | Q96RT7 | |
| SVLSGIGSVSHHVVS | 361 | Q92616 | |
| VSTDHSVPIGNGHVA | 1361 | P23471 | |
| KAVASGQTQTGAVTH | 1001 | A7KAX9 | |
| VAHVDGVDLHVANTG | 276 | Q9P0J1 | |
| AVTGGHAQIQAGTHT | 281 | Q9UBG3 | |
| AVTGGHTQIQAGSHT | 341 | Q9UBG3 | |
| THLIGNIKQGHGTES | 256 | Q969R8 | |
| HSVGVSSVAGTSHAV | 551 | Q68CR7 | |
| VQAVHKAAHFGQGTG | 396 | P21757 | |
| GHHVVFGQVISGQEV | 136 | Q13427 | |
| GDTHTLTVHGAQVLD | 1771 | Q5VST9 | |
| VAVGSAVGHTQGHAV | 66 | Q5T1J5 | |
| QGHVTHQALVGTNTT | 211 | Q8TCB0 | |
| IFVVGGHNGVSHLSS | 481 | Q9NXS3 | |
| SNQHVTLDHEGVGSG | 766 | Q9P2K1 | |
| TGTHKVTVLFAGQHI | 351 | P21333 | |
| HVAVTVGGSNGHFEL | 391 | P07954 | |
| LHSASSGVEKQVEHG | 1316 | Q8N3K9 | |
| GSHVSTAAVVREQHG | 41 | Q86WU2 | |
| NSHVDHGTGALVISS | 516 | O75165 | |
| GAGHFRSQHTTEVVG | 256 | P13612 | |
| VIHKTGHIAAGTSTN | 211 | P20933 | |
| SASGVGGQQFLHIIH | 151 | Q9Y4X4 | |
| TINIGTIGHVAHGKS | 41 | Q2VIR3 | |
| VTVAGGVHISGLHTE | 1086 | P49327 | |
| GQGVHHAASQFGKET | 351 | Q6UWP8 | |
| FGQGVHHAASQVGKE | 386 | Q6UWP8 | |
| AVQGFHTGVHQAGKE | 476 | Q6UWP8 | |
| VLVTVALASAHHGGE | 6 | P15086 | |
| ASVIAVTIQGGAHHL | 431 | Q9UHL4 | |
| THSHGVKTGQCVVFN | 151 | O15547 | |
| VAVHCGKVDTNTHGS | 861 | Q92833 | |
| VTHGGIHATATQVSA | 316 | O14926 | |
| QSLHNIGSVVQHSEG | 171 | O00233 | |
| QNEHHLEGGFSIGSV | 541 | Q13049 | |
| SGNKEIISHISQHGG | 756 | A6NHR9 | |
| QVAHSGAKASVVDGT | 401 | O60502 | |
| GGVPSVSHVTHARHQ | 276 | Q92546 | |
| HIGATVSHQTDFGAN | 131 | Q9HCM1 | |
| THSIHSAIHSIGGIQ | 486 | Q8NFP9 | |
| ARHNIAGTTHSGAEK | 651 | Q05209 | |
| VNNSTTHRGGHVVVQ | 91 | Q9P2U7 | |
| THRGGHVVVQKAQFS | 96 | Q9P2U7 | |
| PKAVVTHSSGNHGQA | 76 | Q9GZT4 | |
| GHSVAVTDVNGDGRH | 321 | P08514 | |
| EINHGHIVTVASSLG | 186 | Q8IZV5 | |
| IGSGGSSHREIHVKQ | 271 | Q8NEY3 | |
| HVAGGHSIAANVNSP | 1586 | Q86UP3 | |
| GEVGTGHSSLNTHIR | 111 | P17024 | |
| GQNSTLVIHKAIHTG | 381 | Q96N58 | |
| ASHHSGGATVVTAAV | 1366 | Q96RL7 | |
| ANGSTKTNHVHITGI | 496 | P40200 | |
| AAAAAAAGQIHHVTQ | 36 | O15270 | |
| HHTLNVGQDGAVDIS | 226 | Q8IV35 | |
| GVHSLASGTGHVQVA | 1391 | Q9BZZ2 | |
| NIVIASTGHRHSQGE | 2326 | Q86WI1 | |
| VGQHIENVSSSHGKG | 196 | Q9UBS9 | |
| ISKAGLNVHNSHVTG | 406 | Q9UKN8 | |
| EGGQSAAAHSAHTVK | 856 | Q96JH7 | |
| GEQSQVAHGTNGIHV | 336 | P36941 | |
| AQSTLIHHQAIHGVG | 701 | P0CJ79 | |
| VVGQELLTAGHHGAS | 201 | Q96AY4 | |
| SSNVVHAIKDGGFTH | 566 | P86452 | |
| SSALIQHQGVHTGDK | 501 | P17020 | |
| VLNHAEGLGAAHTTI | 171 | Q9ULC8 | |
| HVSRQVTSSGVSHGG | 106 | O94901 | |
| THVTSLQGGHAATVR | 311 | Q96FK6 | |
| LTSDGHVVVADSGNH | 721 | Q9C040 | |
| IQGSTHAGGFHNVLE | 201 | Q1EHB4 | |
| GQNSALVIHKAIHTG | 256 | Q6ZNG1 | |
| TGQGNTEVIHTGTLH | 61 | Q5VIY5 | |
| VGSHLQAHQISHTGE | 371 | Q02386 | |
| LTSDGHVVVADAGNH | 721 | O75382 | |
| NGHARIHGGTNQVTK | 1031 | Q96PN7 | |
| TINIGTIGHVAHGKS | 41 | P41091 | |
| EAIHHNKISIVGTGS | 16 | Q6ZMR3 | |
| VHAVGISTLAAGHKT | 666 | P22033 | |
| NDVRHAKSGGTALHV | 191 | O14974 |